What Analyst Projections for Key Metrics Reveal About Cognizant (CTSH) Q2 Earnings
Werte in diesem Artikel
In its upcoming report, Cognizant (CTSH) is predicted by Wall Street analysts to post quarterly earnings of $1.26 per share, reflecting an increase of 7.7% compared to the same period last year. Revenues are forecasted to be $5.19 billion, representing a year-over-year increase of 7.1%.Over the last 30 days, there has been an upward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.Given this perspective, it's time to examine the average forecasts of specific Cognizant metrics that are routinely monitored and predicted by Wall Street analysts.According to the collective judgment of analysts, 'Revenue- Products and Resources' should come in at $1.25 billion. The estimate points to a change of +11% from the year-ago quarter.Based on the collective assessment of analysts, 'Revenue- Health Sciences' should arrive at $1.61 billion. The estimate suggests a change of +10.1% year over year.Analysts predict that the 'Revenue- Financial services' will reach $1.52 billion. The estimate suggests a change of +5.3% year over year.The combined assessment of analysts suggests that 'Revenue- Communications, Media and Technology' will likely reach $826.36 million. The estimate indicates a year-over-year change of +1.3%. View all Key Company Metrics for Cognizant here>>> Shares of Cognizant have demonstrated returns of -1.1% over the past month compared to the Zacks S&P 500 composite's +4.6% change. With a Zacks Rank #2 (Buy), CTSH is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .#1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cognizant Technology Solutions Corporation (CTSH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Cognizant und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Cognizant
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cognizant
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Cognizant Corp.
Analysen zu Cognizant Corp.
Datum | Rating | Analyst | |
---|---|---|---|
03.05.2019 | Cognizant Hold | Needham & Company, LLC | |
03.05.2019 | Cognizant Perform | Oppenheimer & Co. Inc. | |
07.02.2019 | Cognizant Outperform | BMO Capital Markets | |
02.11.2018 | Cognizant Market Perform | BMO Capital Markets | |
08.02.2018 | Cognizant Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
07.02.2019 | Cognizant Outperform | BMO Capital Markets | |
02.11.2018 | Cognizant Market Perform | BMO Capital Markets | |
08.02.2018 | Cognizant Overweight | Barclays Capital | |
08.02.2018 | Cognizant Strong Buy | Needham & Company, LLC | |
08.11.2017 | Cognizant Buy | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
03.05.2019 | Cognizant Hold | Needham & Company, LLC | |
03.05.2019 | Cognizant Perform | Oppenheimer & Co. Inc. | |
10.01.2017 | Cognizant Technology Solutions Hold | Loop Capital | |
30.09.2016 | Cognizant Technology Solutions Hold | Argus Research Company | |
09.09.2016 | Cognizant Technology Solutions Neutral | Wedbush Morgan Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
02.03.2009 | Cognizant Technology underperform | Wachovia Securities, LLC | |
18.12.2006 | Update Cognizant Technology Solutions Corp.: Under | HSBC Securities |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cognizant Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen